Bioavailability and bioequivalence studies are vital for ensuring the quality, safety, and effectiveness of drug products. They provide valuable insights into selecting the right formulations, determining proper dosing schedules, and evaluating the interchangeability of various drug products. Regulatory bodies typically require such data during the drug approval process to ensure that generic products are therapeutically equivalent to their reference products and can be substituted safely.